Network variation - HIF signaling |
ENTRY | nt06542 |
Name | HIF signaling |
Category | Pathway view; Signal transduction |
Pathway | hsa04066 HIF-1 signaling pathway |
Disease | H00021 Renal cell carcinoma H00559 von Hippel-Lindau syndrome |
Display | drug-target relation disease type |
Disease name | Disease category | ||
ECYT4 | H00236 | Congenital polycythemia | Hematologic disease |
ECYT5 | H00236 | Congenital polycythemia | Hematologic disease |
ECYT3 | H00236 | Congenital polycythemia | Hematologic disease |
RCC | H00021 | Renal cell carcinoma | Cancer |
RCC/VHLS/ECYT2 | H00021 | Renal cell carcinoma | Cancer |
H00559 | von Hippel-Lindau syndrome | Congenital malformation | |
H00236 | Congenital polycythemia | Hematologic disease |
Drug name | ||
D1 | D11954 | Belzutifan (JAN/USAN/INN) |